Nuvo Pharmaceuticals Inc NRIFF

RE: comparison

[Landro]

Thanks for your post, I think it pretty much sums it up. As for management, I will respectfully disagree with your assessment. I still believe that they mismanaged the PR opportunity that was given by the FDA approval, I also still believe that having two CEO's is not a great idea and that, if NRI is such a great buying opportunity at these price, they should immidiatly initiate a share buy-back plan. As you put it, I would love to see them manage in a way that rewards us folks who have been supportive for all these years (8 in my case).

Cheers,

L.